A Study to Evaluate Fecal Microbiota Transplantation Engraftment in IBS
NCT ID: NCT02847481
Last Updated: 2019-12-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
80 participants
INTERVENTIONAL
2016-05-31
2018-08-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
fecal microbiota transplantation
fecal microbiota transplantation
fecal microbiota transplantation
fecal microbiota transplantation
placebo fecal microbiota transplantation
placebo fecal microbiota transplantation
placebo fecal microbiota transplantation
placebo fecal microbiota transplantation
FMT after antibiotic pretreatment v1
fecal microbiota transplantation after antibiotic pretreatment
fecal microbiota transplantation
fecal microbiota transplantation
FMT with antibiotic pre-treatment (v1)
FMT with antibiotic pre-treatment (v1)
FMT after antibiotic pretreatment v2
fecal microbiota transplantation after antibiotic pretreatment
fecal microbiota transplantation
fecal microbiota transplantation
FMT with antibiotic pre-treatment (v2)
FMT with antibiotic pre-treatment (v2)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
fecal microbiota transplantation
fecal microbiota transplantation
placebo fecal microbiota transplantation
placebo fecal microbiota transplantation
FMT with antibiotic pre-treatment (v1)
FMT with antibiotic pre-treatment (v1)
FMT with antibiotic pre-treatment (v2)
FMT with antibiotic pre-treatment (v2)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
OpenBiome
INDUSTRY
Beth Israel Deaconess Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anthony Lembo
Associate Professor of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anthony Lembo, MD
Role: PRINCIPAL_INVESTIGATOR
Beth Israel Deaconess Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Singh P, Alm EJ, Kelley JM, Cheng V, Smith M, Kassam Z, Nee J, Iturrino J, Lembo A. Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D. Gut Microbes. 2022 Jan-Dec;14(1):2020067. doi: 10.1080/19490976.2021.2020067.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015P000211
Identifier Type: -
Identifier Source: org_study_id